EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Lipidomic Profile Signature of Active Acromegaly and Relationships to Cardiovascular Disease

Oana Stănoiu-Pînzariu iD, Thalijn L C Wolters iD, Carmen Socaciu iD, Cristina Alina Silaghi, Ana Valea iD, Ioana Popa-Ilie iD, Georgeta Hazi, Andreea Iulia Socaciu, Romana Teodora Netea-Maier iD, Carmen Emanuela Georgescu

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27021082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Oana Stănoiu-Pînzariu und 9 weiteren Autor:innen. Beteiligte Einrichtung: 5th Department of Medical Sciences, Department of Endocrinology, Iuliu Haţieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Acromegaly, Lipidomics, Cardiovascular Diseases, Lipids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acromegaly is a rare endocrine disease characterized by multiple metabolic abnormalities and high cardiovascular risk. This cross-sectional study evaluated the lipidomic serum profile of 109 participants (59 acromegaly patients versus 50 healthy controls) via high-performance liquid chromatography combined with mass spectrometry (HPLC-MS). The lipidomic profile that differentiated acromegaly from controls included sphingomyelins (SMs), glycerophospholipids, glycerolipids, ceramides, fatty acids, wax esters (WEs), carnitines, and sterol (ST) lipids. SM 34:0;O2 and phosphorylcholine best distinguished acromegaly patients from controls (VIP > 2.49). SM 34:0;O2 levels were significantly elevated in treatment-naïve versus uncontrolled patients (p < 0.0001). Furthermore, SM 34:0;O2 positively correlated with random GH and IGF-1. Lack of therapy predicted SM 34:0;O2 serum titers in acromegaly. Profound alterations of glycerophospholipids and sphingolipids were detected in acromegaly patients with cardiovascular complications. ST 24:1;O3, ceramide (Cer) 38:0;O4, and WE 34:1 were significantly increased in both hypertensive acromegaly patients and those with heart failure in comparison to patients without cardiovascular impairment. In conclusion, SM 34:0;O2 and phosphorylcholine emerged as potential lipidomic biomarkers in acromegaly. Moreover, SM 34:0;O2 potentially reflects disease severity. Identifying lipidomic profile alterations in acromegaly patients with cardiac involvement may provide a basis for further insights into the cardiovascular pathogenesis of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyLipidomicsCardiovascular DiseasesLipidsHumansFemaleMaleMiddle AgedAdultBiomarkersCross-Sectional StudiesChromatography, High Pressure Liquid

Stichwörter der Autor:innen

GH-secreting pituitary adenomaacromegalyhigh-performance liquid chromatographylipidomicsmass spectrometry

Substanzen

BiomarkersLipids

Autor:innen und Institutionen

  • 5th Department of Medical Sciences, Department of Endocrinology, Iuliu Haţieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
  • Endocrinology Clinic, Cluj County Emergency Clinical Hospital, 400349 Cluj-Napoca, Romania.
  • Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.
  • RTD Center of Applied Biotechnology BIODIATECH, SC Proplanta, 400478 Cluj-Napoca, Romania.
  • Department of Occupational Health, Iuliu Haţieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.

ORCID-Profile: Oana Stănoiu-Pînzariu, Thalijn L C Wolters, Carmen Socaciu, Ana Valea, Ioana Popa-Ilie, Romana Teodora Netea-Maier

Förderung

  • "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania

Zitieren

APA

Stănoiu-Pînzariu, O., Wolters, T. L. C., Socaciu, C., Silaghi, C. A., Valea, A., Popa-Ilie, I., Hazi, G., Socaciu, A. I., Netea-Maier, R. T., & Georgescu, C. E. (2026). Serum Lipidomic Profile Signature of Active Acromegaly and Relationships to Cardiovascular Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021082

Vancouver

Stănoiu-Pînzariu O, Wolters TLC, Socaciu C, Silaghi CA, Valea A, Popa-Ilie I, et al. Serum Lipidomic Profile Signature of Active Acromegaly and Relationships to Cardiovascular Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021082

BibTeX
@article{StnoiuPnzariu2026,
  author = {Stănoiu-Pînzariu, Oana and Wolters, Thalijn L C and Socaciu, Carmen and Silaghi, Cristina Alina and Valea, Ana and Popa-Ilie, Ioana and Hazi, Georgeta and Socaciu, Andreea Iulia and Netea-Maier, Romana Teodora and Georgescu, Carmen Emanuela},
  title = {Serum Lipidomic Profile Signature of Active Acromegaly and Relationships to Cardiovascular Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27021082}
}
Kostenlos starten →